TRPC3 and cardiac hypertrophy: ,313 In vivo, Pyr3 reduces cardiac hypertrophy and transition to heart failure in mice subjected to pressure overload,312 whereas Pyr10-mediated TRPC3 inhibition alleviates systemic inflammatory responses in mice after treatment with lipopolysaccharide.197